• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素激动剂下调 IVF 和 ICSI 周期中取卵时机的随机临床试验。

Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial.

机构信息

Department of Obstetrics and Gynaecology, Centre of Reproductive Medicine, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Hum Reprod. 2011 May;26(5):1091-6. doi: 10.1093/humrep/der048. Epub 2011 Feb 28.

DOI:10.1093/humrep/der048
PMID:21362684
Abstract

BACKGROUND

The evidence underpinning the timing of an oocyte collection in IVF or ICSI is limited. The aim of this study was to assess the effect of the follicle diameter size of the dominant follicle on ongoing pregnancy rates.

METHODS

We conducted a randomized controlled trial, including women aged between 18 and 43 years who were scheduled for GnRH agonist down-regulated IVF/ICSI treatment in four assisted conception units. Women were randomized between timing oocyte collection when the leading follicle had a diameter of 22 mm or when the leading follicle had a diameter of 18 mm. The primary end-point was ongoing pregnancy, defined as a viable pregnancy at 12 weeks of gestation.

RESULTS

The trial had major problems with recruiting patients and after the planned 2 years of recruiting only half of the aimed 400 inclusions were obtained. We allocated 97 women to the 22-mm group and 93 women to the 18-mm group. In the 22-mm group more women reached an ongoing pregnancy (37 of 97 women, 38%) compared with the 18-mm group (22 of 93 women, 24%) resulting in a relative risk of 1.6 [95% confidence interval (CI): 1.03-2.5]. In a logistic regression analysis, the timing of oocyte collection, adjusted for female age, IVF/ICSI and centre, was still associated with ongoing pregnancy, although the association was no longer statistically significant (OR: 2.0; 95% CI: 0.96-4.2) CONCLUSIONS: This study suggests that delaying the timing of oocyte collection in IVF or ICSI results in better ongoing pregnancy rates, however, larger studies have to be performed to prove or refute these findings.

TRIAL REGISTRATION

ISRCTN24724622.

摘要

背景

在 IVF 或 ICSI 中取卵时机的证据有限。本研究旨在评估优势卵泡直径大小对持续妊娠率的影响。

方法

我们进行了一项随机对照试验,纳入了年龄在 18 至 43 岁之间、计划在四个辅助受孕单位接受 GnRH 激动剂下调 IVF/ICSI 治疗的女性。将这些女性随机分为两组,一组在主导卵泡直径为 22mm 时取卵,另一组在主导卵泡直径为 18mm 时取卵。主要终点是持续妊娠,定义为妊娠 12 周时的活产妊娠。

结果

该试验在招募患者方面遇到了重大问题,在计划的 2 年招募时间内,仅完成了目标 400 例纳入的一半。我们将 97 名女性分配到 22mm 组,93 名女性分配到 18mm 组。在 22mm 组中,更多的女性达到了持续妊娠(97 名女性中有 37 名,38%),而在 18mm 组中,这一比例为 93 名女性中有 22 名(24%),相对风险为 1.6(95%置信区间:1.03-2.5)。在一项 logistic 回归分析中,调整了女性年龄、IVF/ICSI 和中心等因素后,取卵时机仍与持续妊娠相关,尽管这种关联不再具有统计学意义(比值比:2.0;95%置信区间:0.96-4.2)。

结论

这项研究表明,在 IVF 或 ICSI 中延迟取卵时机可提高持续妊娠率,但需要进行更大规模的研究来证实或反驳这些发现。

试验注册

ISRCTN24724622。

相似文献

1
Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial.促性腺激素释放激素激动剂下调 IVF 和 ICSI 周期中取卵时机的随机临床试验。
Hum Reprod. 2011 May;26(5):1091-6. doi: 10.1093/humrep/der048. Epub 2011 Feb 28.
2
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.35 岁及以上接受 IVF/ICSI 的女性中,重组 LH 补充到标准 GnRH 拮抗剂方案中:一项随机对照多中心研究。
Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.
3
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.卵巢过度刺激综合征高危患者辅助生殖周期中促性腺激素释放激素激动剂与拮抗剂的比较。
Hum Reprod. 2005 Sep;20(9):2421-5. doi: 10.1093/humrep/dei074. Epub 2005 May 12.
4
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.在体外受精中,对于卵巢刺激与卵泡波出现的同步化:一项随机对照试验,针对先前反应不佳的患者。
Fertil Steril. 2012 Oct;98(4):881-7.e1-2. doi: 10.1016/j.fertnstert.2012.06.051. Epub 2012 Jul 20.
5
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.在促性腺激素释放激素(GnRH)拮抗剂周期中,取卵前给予GnRH激动剂能否提高妊娠率?一项前瞻性随机研究。
Fertil Steril. 2008 Oct;90(4):1087-93. doi: 10.1016/j.fertnstert.2007.07.1316. Epub 2007 Nov 26.
6
Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation.长期垂体下调后严重子宫内膜异位症患者行 IVF/ICSI 的疗效和安全性。
Reprod Biomed Online. 2014 Jan;28(1):39-46. doi: 10.1016/j.rbmo.2013.09.027. Epub 2013 Oct 9.
7
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的活产率。
Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
8
Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.非月经周期启动卵巢刺激:一项病例对照研究。
Arch Gynecol Obstet. 2013 Oct;288(4):901-4. doi: 10.1007/s00404-013-2794-z. Epub 2013 Apr 3.
9
Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.改良自然周期与控制性卵巢过度刺激 IVF:三种模拟治疗方案的成本效益评估。
Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27.
10
Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.土耳其女性患者中正常反应者体外受精/卵胞浆内单精子注射时促性腺激素释放激素激动剂与拮抗剂的比较
Adv Ther. 2008 Mar;25(3):266-73. doi: 10.1007/s12325-008-0028-8.

引用本文的文献

1
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
2
Explainable artificial intelligence to identify follicles that optimize clinical outcomes during assisted conception.可解释人工智能用于识别在辅助受孕过程中优化临床结果的卵泡。
Nat Commun. 2025 Jan 8;16(1):296. doi: 10.1038/s41467-024-55301-y.
3
Increasing dominant follicular proportion negatively associated with good clinical outcomes in normal ovarian responders using the depot GnRH agonist protocol: a large-sample retrospective analysis.
在使用长效 GnRH 激动剂方案的正常卵巢反应者中,优势卵泡比例增加与良好的临床结局呈负相关:一项大样本回顾性分析。
J Ovarian Res. 2022 Apr 13;15(1):44. doi: 10.1186/s13048-022-00973-7.
4
Can We Prepare IVF Culture Media Two Days Before Ovum Pick up Without Affecting Embryological Parameters? A Retrospective Case-Matched Study.取卵前两天制备体外受精培养基会影响胚胎学参数吗?一项回顾性病例对照研究。
J Reprod Infertil. 2019 Oct-Dec;20(4):209-217.
5
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.在体外受精治疗中诱导卵母细胞最终成熟的新概念。
Endocr Rev. 2018 Oct 1;39(5):593-628. doi: 10.1210/er.2017-00236.
6
Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte.触发日的卵泡大小最有可能产生成熟卵母细胞。
Front Endocrinol (Lausanne). 2018 Apr 25;9:193. doi: 10.3389/fendo.2018.00193. eCollection 2018.
7
With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization.对于卵巢储备功能低的患者,采用高度个体化取卵(HIER)可避免黄体过早化,从而改善 IVF 结局。
J Ovarian Res. 2018 Mar 16;11(1):23. doi: 10.1186/s13048-018-0398-8.
8
The effect of 24 hours delay in oocyte maturation triggering in IVF/ICSI cycles with antagonist protocol and not-elevated progesterone: A randomized control trial.在拮抗剂方案且孕酮未升高的体外受精/卵胞浆内单精子注射周期中,卵母细胞成熟触发延迟24小时的效果:一项随机对照试验。
Int J Reprod Biomed. 2017 Jul;15(7):441-446.
9
Weekend-free scheduled IVF/ICSI procedures and single embryo transfer do not reduce live-birth rates in a general infertile population.无周末安排的体外受精/卵胞浆内单精子注射程序及单胚胎移植并不会降低普通不孕人群的活产率。
Acta Obstet Gynecol Scand. 2017 Dec;96(12):1423-1429. doi: 10.1111/aogs.13235. Epub 2017 Oct 31.
10
Assisted reproductive technologies for male subfertility.针对男性生育力低下的辅助生殖技术。
Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD000360. doi: 10.1002/14651858.CD000360.pub5.